Adenoviral Vector Delivery of vegf, Angiogenin, and gdnf Genes Promotes Angiogenesis in Ischemic Skeletal Muscle

[1]  A. Rizvanov,et al.  Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury , 2019, Neural regeneration research.

[2]  Y. Parfyonova,et al.  Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction , 2018, PloS one.

[3]  E. Akhmetzyanova,et al.  Adipose-Derived Mesenchymal Stem Cell Application Combined With Fibrin Matrix Promotes Structural and Functional Recovery Following Spinal Cord Injury in Rats , 2018, Front. Pharmacol..

[4]  O. Demin,et al.  Correction: A mathematical model of multisite phosphorylation of tau protein , 2018, PloS one.

[5]  K. Webster,et al.  Vascular Regeneration in Ischemic Hindlimb by Adeno‐Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor , 2016, Journal of the American Heart Association.

[6]  Shenming Wang,et al.  Denervation in Femoral Artery-Ligated Hindlimbs Diminishes Ischemic Recovery Primarily via Impaired Arteriogenesis , 2016, PloS one.

[7]  Y. Diao,et al.  Nerve Growth Factor Promotes Angiogenesis and Skeletal Muscle Fiber Remodeling in a Murine Model of Hindlimb Ischemia , 2016, Chinese medical journal.

[8]  Caixia Liu,et al.  Glial cell line-derived neurotrophic factor induced the differentiation of amniotic fluid-derived stem cells into vascular endothelial-like cells in vitro , 2016, Journal of Molecular Histology.

[9]  Xiao-Rui Zhou,et al.  Clinical Experience of Zhao's Artificial Trachea , 2016, Chinese medical journal.

[10]  G. F. Shaymardanova,et al.  Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat , 2015, Spinal Cord.

[11]  Y. Diao,et al.  [Effects of denervation on angiogenesis and skeletal muscle fiber remodeling of ischemic limbs]. , 2015, Zhonghua yi xue za zhi.

[12]  Corey M. McCann,et al.  Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  M. Wiberg,et al.  Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. , 2014, Stem cells and development.

[14]  Y. Taniyama,et al.  Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent , 2014, Immunology, endocrine & metabolic agents in medicinal chemistry.

[15]  Igor Rudan,et al.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.

[16]  L. Zentilin,et al.  Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia , 2013, Vascular cell.

[17]  M. Blais,et al.  Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. , 2013, Tissue engineering. Part A.

[18]  Shanchun Guo,et al.  Vascular endothelial growth factor receptor-2 in breast cancer. , 2010, Biochimica et biophysica acta.

[19]  R. Shapiro,et al.  Characteristic ribonucleolytic activity of human angiogenin. , 1986, Biochemistry.

[20]  Gavrilenko Av,et al.  [Combination of reconstructive vascular operations with gene-engineering technologies of angiogenesis stimulation: a present-day policy aimed at improving the remote results of treating patients with lower limb chronic ischaemia]. , 2008 .

[21]  Gavrilenko Av,et al.  Genetic engineering potential and perspectives in the management of critical ischemia , 2003 .